Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shankara Annegowda"'
Autor:
Parag Goyal, Harish Venkatraman Pai, Phanichand Kodali, Bhavesh Vats, Navratna Vajpai, Shankara Annegowda, Krishnappa Mane, Shamini Mohan, Shruti Saxena, Anil Bangalore Veerabhadraia, Milee Palande, Preethy Sasankan Nair, Digvijay Chandrashekar More, Umamaheshwara Rao Karudumpa, Kunala Jyothirmai, Adroha Bhattacharya, Frida Almeida, Santosh Gulab Khyade, Shankara Gouda, Daniel J Ranayhossaini, Praveen Reddy Moole, Jeffrey P Smith, Abhijit Barve, Ramakrishnan Melarkode, Rajesh Ullanat
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253168 (2021)
Insulin glargine is a long-acting analogue of human insulin that has been used to manage hyperglycemia in patients with diabetes mellitus (DM) for nearly 20 years. Insulin glargine has a relatively constant concentration-time profile that mimics basa
Externí odkaz:
https://doaj.org/article/6da37cf349e544349ce158046d965d25
Autor:
Namrata Shastri, Shulagna Sharma, Anushikha Thakur, H. Pai, Arnab Bera, Ramakrishnan Melarkode, Shankara Annegowda, Sneha Trivedi, Deepa Mohan, Abhilashi Sahu, Pradip Nair, Sheija Rohil, Pradeep Kabadi, Ranitendranath Tagore, Rajesh Ullanat, Malini Subbarao, Roshni Thomas, Gaurav R Mehta, Parag Goyal, Roopa Venkatachala, Bhavesh Vats, Chethan Gejjalagere Honnappa, Yatika Gokhale, Umamaheshwara Rao K, Laxmi Adhikari
Publikováno v:
Expert Opinion on Biological Therapy. 22:271-298
BACKGROUND Bevacizumab (BEV) is a recombinant humanized monoclonal immunoglobulin G1 antibody that binds to vascular endothelial growth factor (VEGF)-A and acts as an antiangiogenic agent. It is approved for treatment of many cancer indications, incl
Autor:
Daniel J. Ranayhossaini, Santosh Gulab Khyade, Umamaheshwara Rao Karudumpa, Digvijay Chandrashekar More, Bhavesh Vats, Preethy Sasankan Nair, Ramakrishnan Melarkode, Kunala Jyothirmai, Adroha Bhattacharya, Shankara Gouda, Jeffrey P. Smith, Krishnappa Mane, Shamini Mohan, Praveen Reddy Moole, Abhijit Barve, H. Pai, Shankara Annegowda, Navratna Vajpai, Frida Almeida, Anil Bangalore Veerabhadraia, Milee Palande, Parag Goyal, Shruti Saxena, Phanichand Kodali, Rajesh Ullanat
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 6, p e0253168 (2021)
PLoS ONE, Vol 16, Iss 6, p e0253168 (2021)
Insulin glargine is a long-acting analogue of human insulin that has been used to manage hyperglycemia in patients with diabetes mellitus (DM) for nearly 20 years. Insulin glargine has a relatively constant concentration-time profile that mimics basa